New oral anticoagulants are the new standard of care. PRO.

Session: Acute pulmonary embolism: persisting and new controversies

Topic: Acute pulmonary embolism

Speaker: Professor H. Buller (Amsterdam, NL)

Event: ESC CONGRESS 2015

Presentation

About the speaker

Professor Harry Buller

AMC Medical Research BV, Amsterdam (Netherlands (The))

3 presentations

0 follower

9 more presentations in this session

Echocardiography and biomarker testing are mandatory in normotensive patients. PRO.

31 August 2015 08:30 - 08:45

Speaker: Professor A. Torbicki (Otwock, PL)

Thumbnail

Echocardiography and biomarker testing are mandatory in normotensive patients. CONTRA.

31 August 2015 08:45 - 09:00

Speaker: Professor D. Jimenez (Madrid, ES)

Thumbnail

Echocardiography and biomarker testing are mandatory in normotensive patients. REBUTTAL PRO.

31 August 2015 09:00 - 09:05

Speaker: Professor A. Torbicki (Otwock, PL)

Thumbnail

Echocardiography and biomarker testing are mandatory in normotensive patients. REBUTTAL CONTRA.

31 August 2015 09:05 - 09:10

Speaker: Professor D. Jimenez (Madrid, ES)

Thumbnail

Echocardiography and biomarker testing are mandatory in normotensive patients - CONCLUSION

31 August 2015 09:10 - 09:15

Thumbnail

New oral anticoagulants are the new standard of care. CONTRA.

31 August 2015 09:30 - 09:45

Speaker: Professor M. Ezekowitz (Philadelphia, US)

Thumbnail

New oral anticoagulants are the new standard of care. REBUTTAL PRO.

31 August 2015 09:45 - 09:50

Speaker: Professor H. Buller (Amsterdam, NL)

Thumbnail

New oral anticoagulants are the new standard of care. REBUTTAL CONTRA.

31 August 2015 09:50 - 09:55

Speaker: Mr S. Schellong (Dresden, DE)

Thumbnail

New oral anticoagulants are the new standard of care - CONCLUSION

31 August 2015 09:55 - 10:00

Thumbnail